Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component useCLAUDE OSSELAER, Jean; DOYEN, Chantal; CORASH, Laurence et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 7, pp 1412-1422, issn 0041-1132, 11 p., 1Article

An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatmentCAZENAVE, Jean-Pierre; WALLER, Chantal; DEFOIN, Laurence et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 6, pp 1210-1219, issn 0041-1132, 10 p.Article

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatmentOSSELAER, Jean C; MESSE, Nathalie; CORASH, Laurence et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 6, pp 1061-1071, issn 0041-1132, 11 p.Article